| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.3 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.4 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |